Fibroma clinical trials

The registry lists 19 studies for Fibroma across more than 10 countries. 4 are recruiting or about to start. 6 of them are mainly about Fibroma (how this is decided). Per ClinicalTrials.gov, last updated 2026-06-17. Counting its 2 narrower conditions too, such as Dupuytren Contracture: 163 studies, 40 open.

Get an email when these change. Save the Fibroma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 5
Status unknown: 5
Recruiting: 3
Active, not recruiting: 2
Terminated: 2
Withdrawn: 1

Phase

Phase 2: 7
Phase 1: 2
Phase 4: 1

Where

United States: 7
Denmark: 2
Guam: 1
Spain: 1
Italy: 1
France: 1

Who runs them

Children's Hospital of Philadelphia (1) · Repros Therapeutics Inc. (1) · Immunitor LLC (1) · Novartis Pharmaceuticals (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · Zealand University Hospital (1) · Oslo University Hospital (1) · Memorial Sloan Kettering Cancer Center (1)

What is being tested here

Drugs under test in Fibroma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Imatinib	0	0	2
Ipilimumab	0	0	1
Nivolumab	0	0	1
Seclidemstat	0	0	1
Triamcinolone Acetonide	0	0	1
Triamcinolone	0	0	1
Telapristone acetate	0	0	1
Sirolimus	0	0	1
Hydroxyurea	0	0	1

Coming up

0phase 3 studies under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Feb 2027Observing People With Desmoid-Type Fibromatosis · Memorial Sloan Kettering Cancer Center

Who these studies take

Of the 3 Fibroma studies recruiting now, 1 (33%) set no upper age limit and 1 (33%) stop at 75 or younger. 0 (0%) take children under 18. 1 (33%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	0 (0%)	0 (0%)
18	1 (33%)	1 (33%)
30	1 (33%)	1 (33%)
40	2 (67%)	1 (33%)
50	3 (100%)	2 (67%)
65	2 (67%)	2 (67%)
75	2 (67%)	2 (67%)
85	2 (67%)	2 (67%)

Across all 19 studies, recruiting or not: 37% stop at 75 or younger and 32% at 65; 32% take children; 37% are for women only and 0% for men only; 16% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 19 of 19. search them.